Advances in Devices to Treat Nonmelanoma Skin Cancer

The presentation discusses advances in devices for treating nonmelanoma skin cancer, specifically focusing on controlled hypothermia and apoptosis. The speaker, a former Mohs surgeon who shifted focus to laser and device development, emphasizes the potential decline in Mohs surgery due to emerging techniques such as topical agents and injections. He highlights the effectiveness of controlled hypothermia in inducing programmed cell death in skin cells through precise temperature control, demonstrating that specific heat levels can significantly affect treatment outcomes. The speaker shares personal experiences and images illustrating the progress of treatments and the use of a robotic Arrhenius dosage sensing device, which provides real-time temperature readings for consistent treatment. He also notes the importance of artificial intelligence in identifying tumors more effectively during procedures. The overall conclusion is that controlled hypothermia and advanced device technologies can effectively treat basal cell cancers with less invasive methods than traditional Mohs surgery, potentially improving patient satisfaction and outcomes.